HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Management of infantile polyposis syndrome.

Abstract
A boy with generalised infantile polyposis syndrome is reported to highlight the difficulties in management. Despite attempts to reduce polyp mass by regular endoscopic polypectomy, daily transfusions of blood products, and a trial of the non-steroidal anti-inflammatory agent sulindac, his condition gradually deteriorated and he died of septicaemia.
AuthorsG J Stiff, A Alwafi, H Jenkins, J Lari
JournalArchives of disease in childhood (Arch Dis Child) Vol. 73 Issue 3 Pg. 253-4 (Sep 1995) ISSN: 1468-2044 [Electronic] England
PMID7492168 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Anti-Inflammatory Agents, Non-Steroidal
  • Sulindac
Topics
  • Anti-Inflammatory Agents, Non-Steroidal (therapeutic use)
  • Blood Component Transfusion
  • Colonic Polyps (therapy)
  • Endoscopy
  • Fatal Outcome
  • Humans
  • Infant
  • Male
  • Sepsis (etiology)
  • Sulindac (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: